560P Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment
| Autor: | Pedrazzoli, A.B. Azaro, Moreno, V., Gomez-Roca, C.A., Even, C., Cassier, P., Guerrero, T.C. Hernandez, de Miguel, M., Korakis, I., Purcea, D., Roy, E., Gollmer, K., Riff, C., Szyldergemajn, S.A., Calvo, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S483-S483 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|